Follow along with the video below to see how to install our site as a web app on your home screen.
Note: This feature may not be available in some browsers.
That’s going to be an issue as long as our current system remains in tact. The people with the education and expertise to conduct research into pharmaceuticals tend to be the same people who work for pharmaceutical companies or have worked for them in the past. This isn’t a very large group of people we’re talking about.I have no idea about the risks of vaccines and believe they are good based entirely off my casual observation. WTS I would like to see some research done by those who are not connected at the hip with big pharma. People do get rich off war and sickness.
No one getting a PhD in biomedical sciences or pharmaceutical sciences should be going into debt to get the degree. Tuition waiver and a $25-35K stipend are typical.That’s going to be an issue as long as our current system remains in tact. The people with the education and expertise to conduct research into pharmaceuticals tend to be the same people who work for pharmaceutical companies or have worked for them in the past. This isn’t a very large group of people we’re talking about.
If someone goes to school for this, likely taking on massive amounts of debt to do so, they’re basically forced to work for big pharma at some point in their career to pay it back. Maybe they can go into government service after that at a severe pay cut.
I get what you’re saying about the “revolving door” though.
That is what I initially thought until I read the letter from his lawyers. It appears she was talking about things he did in advising Pence in the past.How? Those comments are predictive, not statements of prior fact. And Patel is about as public a figure as you can get right now. Any lawsuit would be pure — oh what’s that word??? — lawfare.
It was expected and the market response so far has been yawn. Still in a much more comfortable range.Inflation ticked back up. going to be interesting